Non-coding RNAs in bladder cancer, a bridge between gut microbiota and host? DOI Creative Commons
Jun Zou, Baisheng Xu,

Peiyue Luo

и другие.

Frontiers in Immunology, Год журнала: 2024, Номер 15

Опубликована: Ноя. 19, 2024

In recent years, the role of gut microbiota (GM) in bladder cancer has attracted significant attention. Research indicates that GM not only contributes to carcinogenesis but also influences efficacy adjuvant therapies for cancer. Despite this, interventions targeting have been widely employed prevention and treatment cancer, mainly due incomplete understanding complex interactions between host flora. Simultaneously, aberrantly expressed non-coding RNAs (ncRNAs) frequently associated with playing crucial roles processes such as cell proliferation, invasion, drug resistance. It is known regulation GM-mediated pathophysiological partly regulated through epigenetic pathways. At same time, ncRNAs are increasingly regarded signaling molecules involved regulation. Accordingly, this review analyzes closely related context occurrence treatment, summarizes their interaction cancer-related phenotypes. The aim delineate a regulatory network provide new perspective study

Язык: Английский

Advances in exosomes utilization for clinical applications in cancer DOI
Inês A. Batista, José Carlos Machado, Sónia A. Melo

и другие.

Trends in cancer, Год журнала: 2024, Номер 10(10), С. 947 - 968

Опубликована: Авг. 20, 2024

Язык: Английский

Процитировано

11

Recent Exploration of Solid Cancer Biomarkers Hidden Within Urine or Blood Exosomes That Provide Fundamental Information for Future Cancer Diagnostics DOI Creative Commons

Tomoaki Hara,

Sikun Meng, Aya Hasan Alshammari

и другие.

Diagnostics, Год журнала: 2025, Номер 15(5), С. 628 - 628

Опубликована: Март 5, 2025

Cancer cells exhibit abnormal behavior compared to normal cells. They ignore growth arrest signals such as contact inhibition, a mechanism that stops their proliferation when they collide with surrounding cells, and proliferate in an uncontrolled manner, destroying tissue. Early detection treatment of cancer are therefore important for healthy longevity. differ from characteristic gene expression due abnormalities. markers reflect these characteristics have been searched applied diagnosis. Although analysis blood antigens has the main method, further development diagnostic system is needed early cancer. Next-generation sequencers improved technology, making it possible analyze detailed nucleic acid molecules or urine. In addition, release extracellular vesicles, exosomes, which known contain may serve markers. This review summarizes latest findings on exosomal

Язык: Английский

Процитировано

0

The diagnostic accuracy of urine-derived exosomes for bladder cancer: a systematic review and meta-analysis DOI Creative Commons
Chunyue Long,

Hongjin Shi,

Jingyu Li

и другие.

World Journal of Surgical Oncology, Год журнала: 2024, Номер 22(1)

Опубликована: Окт. 29, 2024

Язык: Английский

Процитировано

2

Recent Electrochemical Advancements for Liquid-Biopsy Nucleic Acid Detection for Point-of-Care Prostate Cancer Diagnostics and Prognostics DOI Creative Commons
Joseph Broomfield, Melpomeni Kalofonou, Charlotte L. Bevan

и другие.

Biosensors, Год журнала: 2024, Номер 14(9), С. 443 - 443

Опубликована: Сен. 14, 2024

Current diagnostic and prognostic tests for prostate cancer require specialised laboratories have low specificity detection. As such, recent advancements in electrochemical devices point of care (PoC) detection seen significant interest. Liquid-biopsy relevant circulating exosomal nucleic acid markers presents the potential minimally invasive testing. In combination, DNA RNA present an innovative approach novel diagnostics, potentially directly within clinic. Recent research impedance spectroscopy, voltammetry, chronoamperometry potentiometric sensing using field-effect transistors will be discussed. Evaluation PoC relevance these techniques their fulfilment WHO’s REASSURED criteria medical diagnostics is described. Further areas exploration testing progression to clinical implementation are assessed.

Язык: Английский

Процитировано

1

Urinary miRNAs in bladder cancer DOI

Amrit Chattopadhaya,

Sukhad Kural, Ashish Verma

и другие.

Clinica Chimica Acta, Год журнала: 2024, Номер unknown, С. 120113 - 120113

Опубликована: Дек. 1, 2024

Язык: Английский

Процитировано

1

Expanding frontiers in liquid biopsy-discovery and validation of circulating biomarkers in renal cell carcinoma and bladder cancer DOI
Sabareeswaran Krishnan, Shruthi Kanthaje, P. D. Rekha

и другие.

International review of cell and molecular biology, Год журнала: 2024, Номер unknown, С. 135 - 197

Опубликована: Сен. 12, 2024

Язык: Английский

Процитировано

0

Non-coding RNAs in bladder cancer, a bridge between gut microbiota and host? DOI Creative Commons
Jun Zou, Baisheng Xu,

Peiyue Luo

и другие.

Frontiers in Immunology, Год журнала: 2024, Номер 15

Опубликована: Ноя. 19, 2024

In recent years, the role of gut microbiota (GM) in bladder cancer has attracted significant attention. Research indicates that GM not only contributes to carcinogenesis but also influences efficacy adjuvant therapies for cancer. Despite this, interventions targeting have been widely employed prevention and treatment cancer, mainly due incomplete understanding complex interactions between host flora. Simultaneously, aberrantly expressed non-coding RNAs (ncRNAs) frequently associated with playing crucial roles processes such as cell proliferation, invasion, drug resistance. It is known regulation GM-mediated pathophysiological partly regulated through epigenetic pathways. At same time, ncRNAs are increasingly regarded signaling molecules involved regulation. Accordingly, this review analyzes closely related context occurrence treatment, summarizes their interaction cancer-related phenotypes. The aim delineate a regulatory network provide new perspective study

Язык: Английский

Процитировано

0